Results 21 to 30 of about 7,267,063 (234)

The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review [PDF]

open access: yesFrontiers in Cell and Developmental Biology
Mesenchymal stromal stem cells (MSCs) possess a remarkable potential for numerous clinical applications due to their unique properties including self-renewal, immunomodulation, paracrine actions and multilineage differentiation.
Ana Bajc Česnik   +2 more
doaj   +2 more sources

Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products [PDF]

open access: yesTürk Oftalmoloji Dergisi, 2018
Due to recent advances in science and technology, when the products used in therapy are examined, ophthalmology has a priority in terms of research and development, preclinical and clinical studies of innovative drugs, medical devices and drug-medical ...
Türkan Eldem, Bora Eldem
doaj   +2 more sources

Therapeutic Proteins and Advanced Therapy Medicinal Products [PDF]

open access: yes, 2023
This chapter is divided in two parts: Therapeutic proteins and Advanced Therapy Medicinal Products (ATMPs). Therapeutic Proteins. Therapeutic proteins are large molecules that are different from low molecular weight medicines. They consist of amino acid chains, sometimes decorated with polysaccharides (glycoproteins) that fold in space in secondary and
Eppink, Michel   +6 more
openaire   +5 more sources

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States [PDF]

open access: yesFrontiers in Pharmacology, 2019
Advanced therapy medicinal products (ATMPs) are a fast-growing field of innovative therapies. The European Union (EU) and the United States (US) are fostering their development.
Carolina Iglesias-Lopez   +5 more
doaj   +2 more sources

Editorial: Clinical Translation and Commercialisation of Advanced Therapy Medicinal Products [PDF]

open access: yesFrontiers in Bioengineering and Biotechnology, 2020
Ivan Martin   +4 more
doaj   +2 more sources

Whither Advanced Therapy Medicinal Products? [PDF]

open access: yesTransfusion Medicine and Hemotherapy, 2013
The topic of this special issue of Transfusion Medicine and Hemotherapy is advanced therapies and tissue engineering. The legislative framework that regulates these fields in Europe is based on two Directives (and their amendments) of the European Commission [1, 2] and has been legally binding in all EC member states since December 2008.
Mark D, Smith   +3 more
openaire   +2 more sources

Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium

open access: yesPharmaceutics, 2021
Among several requirements for the manufacture of Advanced Therapy Medicinal Products (ATMP) are: following the guidelines of a pharmaceutical quality system, complying with Good Manufacturing Practice (GMP) and access to a cleanroom fulfilling strict ...
Silvia Berisa-Prado   +9 more
doaj   +1 more source

Role of HLA-G in Viral Infections

open access: yesFrontiers in Immunology, 2022
The human leukocyte antigen (HLA)-G is a non-classical HLA class I molecule, which has distinct features to classical HLA-A, -B, -C antigens, such as a low polymorphism, different splice variants, highly restricted, tightly regulated expression and ...
Simon Jasinski-Bergner   +4 more
doaj   +1 more source

Gene and Cell Therapies Overview Under the Light of Health Economics [PDF]

open access: yesHealth Economics and Management Review, 2022
With the increase in drug development studies for rare diseases, gene therapies have recently come to the fore more frequently. In addition to orphan drugs used in the treatment of rare diseases, advanced therapy medicinal products have been developed ...
Ekin Begum Karahan, Guvenc Kockaya
doaj   +1 more source

Home - About - Disclaimer - Privacy